DPP8/9 inhibition attenuates the TGF-β1-induced excessive deposition of extracellular matrix (ECM) in human mesangial cells via Smad and Akt signaling pathway.

[1]  Xuefei Tian,et al.  New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors , 2022, Frontiers in Pharmacology.

[2]  Xiancheng Li,et al.  Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cells. , 2021, Pharmacological research.

[3]  S. Gygi,et al.  DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation , 2021, Nature.

[4]  N. Frangogiannis,et al.  The role of Smad signaling cascades in cardiac fibrosis. , 2020, Cellular signalling.

[5]  De-juan Sun,et al.  Si-Miao-Yong-An Decoction attenuates isoprenaline-induced myocardial fibrosis in AMPK-driven Akt/mTOR and TGF-β/SMAD3 pathways. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  B. Zhang,et al.  PTEN improve renal fibrosis in vitro and in vivo through inhibiting FAK/AKT signaling pathway , 2019, Journal of cellular biochemistry.

[7]  I. Plastira,et al.  Saxagliptin but Not Sitagliptin Inhibits CaMKII and PKC via DPP9 Inhibition in Cardiomyocytes , 2018, Front. Physiol..

[8]  Wanrong Wu,et al.  Targeting dipeptidyl peptidase 8 genes inhibits proliferation, migration and invasion by inhibition of cyclin D1 and MMP2MMP9 signal pathway in cervical cancer , 2018, The journal of gene medicine.

[9]  A. Kentsis,et al.  DPP8/9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia , 2018, Nature Medicine.

[10]  S. Sánchez,et al.  Extracellular matrix remodeling and TGF‐β1/Smad signaling in diabetic colon mucosa , 2018, Cell biology international.

[11]  C. Henke,et al.  Extracellular matrix as a driver of progressive fibrosis. , 2018, The Journal of clinical investigation.

[12]  W. Wang,et al.  Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non‐small cell lung cancer (NSCLC) , 2017, International journal of cancer.

[13]  J. Jakić-Razumović,et al.  Dipeptidyl peptidase 9 (DPP9) in human skin cells. , 2017, Immunobiology.

[14]  S. Hörsten,et al.  Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins , 2016, Clinical and experimental immunology.

[15]  A. Lambeir,et al.  The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis , 2015, Front. Immunol..

[16]  Lin Sun,et al.  Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy. , 2015, Current medicinal chemistry.

[17]  Zhangsuo Liu,et al.  Proliferation and Cytokine Production of Human Mesangial Cells Stimulated by Secretory IgA Isolated from Patients with IgA Nephropathy , 2015, Cellular Physiology and Biochemistry.

[18]  Z. Werb,et al.  Remodelling the extracellular matrix in development and disease , 2014, Nature Reviews Molecular Cell Biology.

[19]  S. Hubchak,et al.  Hypoxia-inducible factor-2α and TGF-β signaling interact to promote normoxic glomerular fibrogenesis. , 2013, American journal of physiology. Renal physiology.

[20]  Yiqian Chen,et al.  Advances in Understanding the Expression and Function of Dipeptidyl Peptidase 8 and 9 , 2013, Molecular Cancer Research.

[21]  K. Block,et al.  Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? , 2013, Free radical biology & medicine.

[22]  F. Reinholt,et al.  Diabetic Nephropathy and Extracellular Matrix , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  S. Kaneko,et al.  Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  Rong Wang,et al.  The Role of the p38 MAPK Signaling Pathway in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Renal Tubular Epithelial Cells , 2011, PloS one.

[25]  Kang-Yell Choi,et al.  A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling , 2011, Molecular Cancer Research.

[26]  Xin Chen,et al.  Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor. , 2009, Biochemical pharmacology.

[27]  Hyun Soon Lee,et al.  Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease. , 2009, Histology and histopathology.

[28]  Xin Chen,et al.  Novel isoindoline compounds for potent and selective inhibition of prolyl dipeptidase DPP8. , 2005, Bioorganic & medicinal chemistry letters.

[29]  Y. Kurogi.  Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease , 2003, Medicinal research reviews.

[30]  D. Yue,et al.  The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy. , 1999, Cellular and molecular biology.

[31]  J. Egido,et al.  Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. , 1996, Journal of immunology.

[32]  Jing-hong Zhao.  Mesangial Cells and Renal Fibrosis. , 2019, Advances in experimental medicine and biology.

[33]  Taotao Ma,et al.  TGF-β/Smad and Renal Fibrosis. , 2019, Advances in experimental medicine and biology.

[34]  H. Wilson,et al.  Glomerular epithelial and mesangial cell culture and characterization. , 2012, Methods in molecular biology.